TP53 and cancer: Therefore, Jurma T cells, a TCR-deficient T cell line, were transduced with human αβTCRs directed against the cancer/testis antigen NY-ESO-1157–16529 or with a murine nonsense αβTCR composed of the TCRα chain of an MDM2-specific αβTCR,30 and the TCRβ chain of a p53-specific αβTCR.31